Jin Medical International Ltd.
corporate_fare Company Profile
Jin Medical International Ltd. (NASDAQ:ZJYL) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 14 items for ZJYL at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-24, rated 8/10. Across its 14 most recent items scored 7 or higher, the top rating is 10/10, with 11 rated 8 or above. Recent SEC coverage for ZJYL spans 6-K, 6-K/A, 20-F.
Recent high-impact activity:
- Jin Medical Closes $159.4M VIE Acquisition, Issues 79.8M Shares
- Jin Medical Signs $159M VIE Acquisition for Ginseng Tech Assets, Issuing 71.3M Shares
- Jin Medical Closes $105M VIE Acquisition, Issues 70.6M Shares, and Reports H1 2026 Results
- Jin Medical Shareholders Greenlight Sweeping Governance Overhaul and $105M Acquisition
- Jin Medical International Amends Shareholder Meeting Date for Highly Dilutive Acquisition and Voting Power Shift
Financial Snapshot
Short Interest & Short Volume
4.34 days to coverFINRA reported short interest of 49,143 shares in ZJYL as of the October 15, 2026 settlement, a 29.8% decrease from the prior period — about 4.3 days to cover at its recent average daily volume. On November 2, 2026, 30.7% of ZJYL volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Insider Transactions
ZJYL files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.